A study to determine the safety and effect of antibodies against hepatitis D (the SAMBA-D study)

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-522125-36-00

Acronym

SAMBA-D-001

Enrollment

Registered

2026-01-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis D infection

None listed

Sex/Gender

All

Age

18 Years to No maximum

Denmark, Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026